Lifemel Honey to Reduce Leucopenia During Chemotherapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00243165|
Recruitment Status : Unknown
Verified October 2005 by Rambam Health Care Campus.
Recruitment status was: Not yet recruiting
First Posted : October 21, 2005
Last Update Posted : December 7, 2009
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer||Behavioral: Lifemel honey intake every day||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia|
|Study Start Date :||November 2005|
- Prevention of myelotoxicity-every week during chemotherapy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00243165
|Contact: Georgeta Fried, MDfirstname.lastname@example.org|
|Principal Investigator:||Georgeta Fried, MD||Rambam Health Care Campus|